Cheung A, Driedger A A
Radiology. 1980 Jan;134(1):209-12. doi: 10.1148/radiology.134.1.6153129.
Radioactive phosphorus effected substantial palliation of intractable bone pain in 17 of 33 (51.5%) women with metastatic carcinoma of the breast and in 14 of 15 (93.3%) men with metastatic carcinoma of the prostate. No significant difference in the overall response rate was found between androgen and parathormone priming prior to radiophosphorus therapy. The degree of response was not dependent on total dose of 32P within the range of 9--18 mCi (333--666 MBq). Myelosuppression was a transient complication in 9 of 33 patients with metastatic breast carcinoma and in 7 of 15 patients with metastatic prostate carcinoma. Symptomatic hypercalcemia was an infrequent complication of radiophosphorus therapy irrespective of the priming regimen.
放射性磷使33例（51.5%）转移性乳腺癌女性患者中的17例以及15例（93.3%）转移性前列腺癌男性患者中的14例顽固性骨痛得到显著缓解。在放射性磷治疗前，雄激素和甲状旁腺素预处理之间的总体缓解率未发现显著差异。在9 - 18 mCi（333 - 666 MBq）范围内，缓解程度不依赖于32P的总剂量。骨髓抑制是33例转移性乳腺癌患者中的9例以及15例转移性前列腺癌患者中的7例的短暂并发症。无论预处理方案如何，症状性高钙血症都是放射性磷治疗的罕见并发症。
